Literature DB >> 35059827

Pain management of upper limb fractures in pediatric emergency department versus general orthopedics emergency department.

Dania Takagi1,2, Saharon Less Elazari3,4, Ayelet Shles3,4, Hadas Yechiam3,4, Dana Schujovitzky3,4, Ehud Rosenbloom3,4.   

Abstract

Under treatment of pain is frequently reported in children even in conditions associated with severe pain such as fractures. Recent literature supports adequate and early pain treatment because extreme and uncontrolled pain can lead to hyperalgesia. Since 2017, the treatment of pediatric orthopedic cases in the "Meir" Medical Center was gradually shifted from the orthopedic general emergency department to the pediatric emergency department. The objective was to examine the differences in pain management between the orthopedic and pediatric emergency departments. Upper limb fractures were chosen as a representing case. This retrospective cohort study included children aged 0-18 years that suffered from an upper limb fracture and were admitted to the emergency department in the years 2016 and 2018. In our study, a total of 2520 children suffered from an upper limb fracture and were treated at the Meir Medical Center during the study period. 959 of these children were treated during 2016 in the general emergency department, and 1561 were treated in the pediatric emergency department during 2018. The group characteristics were similar. In the pediatric emergency department compared to general emergency department group, more children received analgesic treatment (47.85% versus 30.4%, p < .001), more opiates were given (13.9% versus 5.3%, p < .001), and the analgesic treatment was more adequate to pain severity. Additionally, sedation was performed more frequently in the pediatric emergency department (21.6% versus 9.5%, p < .001), especially for dislocated fractures (81.5% versus 31.4%, p < .001). COMPLICATIONS: Length of stay, surgery, hospitalization, and recurrent referral rates were similar between the two groups.
CONCLUSIONS: The transfer of orthopedic pediatric cases to the pediatric emergency department showed a notable improvement in pain management without an increase in complications or emergency department length of stay. WHAT IS KNOWN: • Pain management and control is a major issue to address in their treatment. • Traumatic injuries and especially fractures are common causes for ED admissions. WHAT IS NEW: • Comparing pain management and upper limb fractures treatment between general and pediatric ED. • Pain is better treated in the PED than in the GED, without an increased rate of complications.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Analgesia; Long bone fractures; Pain management; Pediatric emergency department; Practice patterns

Mesh:

Year:  2022        PMID: 35059827     DOI: 10.1007/s00431-021-04310-w

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  4 in total

1.  Triage pain scales cannot predict analgesia provision to pediatric patients with long-bone fracture.

Authors:  Yi-Ming Weng; Yu-Che Chang; Yu-Jr Lin
Journal:  Am J Emerg Med       Date:  2010-05       Impact factor: 2.469

2.  Analgesia Use in Children with Acute Long Bone Fractures in the Pediatric Emergency Department.

Authors:  Jennifer Noble; Bradley Zarling; Thomas Geesey; Erich Smith; Ahmad Farooqi; Walid Yassir; Usha Sethuraman
Journal:  J Emerg Med       Date:  2019-11-16       Impact factor: 1.484

3.  Ultrasound-guided hematoma block in distal radial fracture reduction: a randomised clinical trial.

Authors:  Marzieh Fathi; Meysam Moezzi; Saeed Abbasi; Davood Farsi; Mohammad Amin Zare; Peyman Hafezimoghadam
Journal:  Emerg Med J       Date:  2014-07-12       Impact factor: 2.740

4.  The influence of an accredited pediatric emergency medicine program on the management of pediatric pain and anxiety.

Authors:  Tali Capua; Zohar Bar Kama; Ayelet Rimon
Journal:  Isr J Health Policy Res       Date:  2018-03-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.